483
Maryellen Fitzgerald, M.D.Maryellen Fitzgerald, M.D. – FDA 483, Mar 10, 2023
Record Details
An FDA inspection of Maryellen Fitzgerald, M.D. in Watertown, MA, from March 7-10, 2023, identified a significant deviation from the investigational plan. The firm failed to conduct the study according to protocol, specifically regarding subject visit scheduling and laboratory sample collection. This resulted in multiple subjects having critical study visits performed outside the defined windows, indicating issues with clinical trial conduct.
View Company Profile
ID · 1c0bb874-1db6-4398-87c6-04f8512b6e83
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.